Sandra Rocio Montezuma MD
Retinal Disease
Professor, Ophthalmology University of Minnesota Medical School knobloch endowed chair
Join to view full profile
3525 Plymouth BlvdPlymouth, MN 55447
Phone+1 763-273-8800
Dr. Montezuma is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sandra Rocio Montezuma, based in Minneapolis, MN, specializes in ophthalmology with a subspecialty in retinal diseases. Her extensive education includes a residency in ophthalmology and fellowships in surgical retina and vitreous, as well as research, all affiliated with Harvard Medical School. She is experienced in managing conditions such as vitreous detachment, retinal detachment, and retinitis pigmentosa. Dr. Montezuma has contributed to multiple publications in the field and is involved in clinical trials, particularly focusing on retinitis pigmentosa. She holds a Knobloch endowed chair at the University of Minnesota and received a CMS Meaningful Use certification.
Education & Training
Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Surgical Retina and Vitreous, 2008 - 2010- Mass General Brigham/Massachusetts Eye and Ear/Harvard Medical SchoolResidency, Ophthalmology, 2005 - 2008
Brigham and Womens HospitalInternship, Transitional Year, 2004 - 2005
Boston VA Healthcare System (Brockton-West Roxbury)/Harvard Medical SchoolFellowship, Research, 2000 - 2004
Fundacion oftalmologica de Santander Ophthalmology, 1997 - 2000
Certifications & Licensure
MN State Medical License 2010 - 2027
MA State Medical License 2008 - 2012
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Knobloch endowed chair UMN, 2018
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
Clinical Trials
- Oral N-acetylcysteine for Retinitis Pigmentosa Start of enrollment: 2023 Oct 11
Publications & Presentations
PubMed
- 1 citationsReport From the International Conference on Incontinentia Pigmenti: Translating Discovery to Therapy.Reid Wilson, Nicole Somani, Nancy Arias, Audina Berrocal, Connie Chen
American Journal of Medical Genetics. Part A. 2026-10-01 - Clinical features, retinal detachment (RD) rates, and RD prophylaxis in patients with genetically confirmed Knobloch Syndrome, a U.S.-based multi-center study.Prethy Rao, Emmanuel Chang, Emily Spoth, Natasha Ferreira Santos da Cruz, Audina Berrocal
Ophthalmology. Retina. 2026-09-08 - Consensus Guidance for Screening, Classification, and Treatment of Retinopathy Associated with Incontinentia Pigmenti.Jade Y Moon, Becky Abbott, Audina Berrocal, Connie Chen, Xi Chen
Ophthalmology Science. 2026-08-01
Professional Memberships
- Fellow
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: